BLFS
Price
$22.36
Change
+$1.72 (+8.33%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
1.09B
87 days until earnings call
MYNZ
Price
$1.49
Change
+$0.06 (+4.20%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
6.55M
23 days until earnings call
Interact to see
Advertisement

BLFS vs MYNZ

Header iconBLFS vs MYNZ Comparison
Open Charts BLFS vs MYNZBanner chart's image
BioLife Solutions
Price$22.36
Change+$1.72 (+8.33%)
Volume$60.35K
Capitalization1.09B
Mainz Biomed
Price$1.49
Change+$0.06 (+4.20%)
Volume$100
Capitalization6.55M
BLFS vs MYNZ Comparison Chart in %
Loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MYNZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLFS vs. MYNZ commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLFS is a Hold and MYNZ is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (BLFS: $20.64 vs. MYNZ: $1.43)
Brand notoriety: BLFS and MYNZ are both not notable
BLFS represents the Pharmaceuticals: Other, while MYNZ is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BLFS: 0% vs. MYNZ: 31%
Market capitalization -- BLFS: $1.09B vs. MYNZ: $6.55M
BLFS [@Pharmaceuticals: Other] is valued at $1.09B. MYNZ’s [@Medical Specialties] market capitalization is $6.55M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $168.51B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.79B. The average market capitalization across the [@Medical Specialties] industry is $9.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLFS’s FA Score shows that 1 FA rating(s) are green whileMYNZ’s FA Score has 1 green FA rating(s).

  • BLFS’s FA Score: 1 green, 4 red.
  • MYNZ’s FA Score: 1 green, 4 red.
According to our system of comparison, both BLFS and MYNZ are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLFS’s TA Score shows that 2 TA indicator(s) are bullish while MYNZ’s TA Score has 5 bullish TA indicator(s).

  • BLFS’s TA Score: 2 bullish, 5 bearish.
  • MYNZ’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, MYNZ is a better buy in the short-term than BLFS.

Price Growth

BLFS (@Pharmaceuticals: Other) experienced а -0.79% price change this week, while MYNZ (@Medical Specialties) price change was +7.52% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.86%. For the same industry, the average monthly price growth was -3.35%, and the average quarterly price growth was +2.88%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +4.25%. For the same industry, the average monthly price growth was +1.87%, and the average quarterly price growth was -1.45%.

Reported Earning Dates

BLFS is expected to report earnings on Nov 06, 2025.

MYNZ is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+1.86% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical Specialties (+4.25% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLFS($1.09B) has a higher market cap than MYNZ($6.55M). BLFS YTD gains are higher at: -20.493 vs. MYNZ (-66.898). BLFS has more cash in the bank: 88.6M vs. MYNZ (978K). MYNZ has less debt than BLFS: MYNZ (8.27M) vs BLFS (26.9M).
BLFSMYNZBLFS / MYNZ
Capitalization1.09B6.55M16,590%
EBITDA2.72MN/A-
Gain YTD-20.493-66.89831%
P/E RatioN/AN/A-
Revenue87.8MN/A-
Total Cash88.6M978K9,059%
Total Debt26.9M8.27M325%
FUNDAMENTALS RATINGS
BLFS: Fundamental Ratings
BLFS
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
96
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
80
P/E GROWTH RATING
1..100
14
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BLFSMYNZ
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
79%
Momentum
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 26 days ago
78%
Bullish Trend 22 days ago
77%
Declines
ODDS (%)
Bearish Trend 11 days ago
85%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 4 days ago
88%
Aroon
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MYNZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCAL15.220.04
+0.26%
California BanCorp
SBFM1.40N/A
N/A
Sunshine Biopharma Inc
TCRX1.64-0.01
-0.61%
TScan Therapeutics
WWD248.45-2.18
-0.87%
Woodward
NSA29.76-0.48
-1.59%
National Storage Affiliates Trust

BLFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with RGEN. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLFS
1D Price
Change %
BLFS100%
N/A
RGEN - BLFS
56%
Loosely correlated
-1.84%
A - BLFS
51%
Loosely correlated
+0.56%
RVTY - BLFS
50%
Loosely correlated
+0.44%
TWST - BLFS
49%
Loosely correlated
+2.56%
AZTA - BLFS
49%
Loosely correlated
-0.34%
More

MYNZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, MYNZ has been loosely correlated with ACRS. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MYNZ jumps, then ACRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MYNZ
1D Price
Change %
MYNZ100%
-1.38%
ACRS - MYNZ
40%
Loosely correlated
+3.82%
STXS - MYNZ
25%
Poorly correlated
+14.16%
SINT - MYNZ
23%
Poorly correlated
+7.64%
BLFS - MYNZ
23%
Poorly correlated
N/A
CVRX - MYNZ
22%
Poorly correlated
+4.32%
More